Cantù G, Solero C L, Matta Velli F, Salvatori P, Pizzi N
Sezione di Chirurgia Cranio-Facciale, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano.
Acta Otorhinolaryngol Ital. 1996 Feb;16(1):16-24.
Between 1987 and 1994 we performed 103 anterior cranio-facial resections in patients affected by tumors involving the ethmoid, the nasal cavities and, sometimes, the orbit, the maxillary and sphenoid sinuses. The cibriform plate was always involved. The tumor invaded the frontal dura in 20 patients without intradural neoplastic vegetations. These were present in 6 cases. Ninety-one of these patients had a malignant tumor; from the histologic point of view we had 50 adenocarcinomas, 16 epidermoid carcinomas, 8 estesioneuroblastomas, 6 adenoid cystic carcinomas, 5 melanomas and 6 infrequent types. The surgical technique became simplier in the second half of our patients. Now we perform a coronal skin incision and prepare a pericranial flap without the galea and use it to reconstruct the cranial base defect without bone or alloplastic material. The frontal craniotomy is rectangular, low and made by an oscillating saw without trephine holes. The posterior section of the skull base for a typical ethmoid tumor is always on the sphenoid roof and the lateral ones on the medial third of the orbital roof, al least in the more interested side. The anterior section is on the frontal sinus floor. The osteotomies may be enlarged according to tumor extension. Our facial incision is paranasal without splitting of the upper lip, but sometimes we used wider skin incisions and osteotomies for tumors involving the maxillary sinus and palate. We had many important complications in the first half of out patients with 7 postoperative deaths but none in the second half. Fifty-five percent of the adenocarcinomas, 7% of the epidermoid carcinomas, 75% of the estesioneuroblastomas, 100% of the adenoid cystic carcinomas and 0% of the melanomas are alive and well. Forty-six patients were previously treated elsewhere and 45 were untreated. The cure rate of these two groups of patients is very different: 38.1% of the first versus 61.9% of the second ones are alive and free of disease. Our experience proves that every transfacial or transnasal resection of an ethmoidal tumor involving the cribriform plate must be avoided.
1987年至1994年间,我们对103例受筛窦、鼻腔,有时还累及眼眶、上颌窦和蝶窦肿瘤影响的患者进行了前颅面切除术。筛板总是受累。20例患者的肿瘤侵犯了额部硬脑膜,但无硬脑膜内肿瘤赘生物。6例存在硬脑膜内肿瘤赘生物。这些患者中有91例患有恶性肿瘤;从组织学角度来看,有50例腺癌、16例表皮样癌、8例嗅神经母细胞瘤、6例腺样囊性癌、5例黑色素瘤和6例罕见类型。在我们治疗的后半部分患者中,手术技术变得更简单。现在我们采用冠状皮肤切口,制备不带帽状腱膜的颅骨膜瓣,并用它来修复颅底缺损,无需使用骨或异体材料。额部开颅术呈矩形,较低,使用摆锯进行,不钻环锯孔。对于典型的筛窦肿瘤,颅底的后部总是位于蝶骨嵴,外侧部分位于眶顶内侧三分之一处,至少在更受影响的一侧是这样。前部位于额窦底部。可根据肿瘤扩展情况扩大截骨范围。我们的面部切口位于鼻旁,不劈开上唇,但有时对于累及上颌窦和腭部的肿瘤,我们会采用更宽的皮肤切口和截骨术。在我们治疗的前半部分患者中出现了许多严重并发症,有7例术后死亡,但后半部分没有。55%的腺癌、7%的表皮样癌、75% 的嗅神经母细胞瘤、100%的腺样囊性癌和0%的黑色素瘤患者存活且状况良好。46例患者此前在其他地方接受过治疗,45例未接受过治疗。这两组患者的治愈率差异很大:第一组患者的治愈率为38.1%,第二组为61.9%,且无疾病存活。我们的经验证明,必须避免对累及筛板的筛窦肿瘤进行任何经面部或经鼻切除术。